Compare UMC & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UMC | MDLN |
|---|---|---|
| Founded | 1980 | 1966 |
| Country | Taiwan | United States |
| Employees | 19097 | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0B | 37.4B |
| IPO Year | 1997 | 2025 |
| Metric | UMC | MDLN |
|---|---|---|
| Price | $18.32 | $34.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $50.48 |
| AVG Volume (30 Days) | ★ 12.9M | 6.8M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $28,432,000,000.00 |
| Revenue This Year | $11.22 | $10.88 |
| Revenue Next Year | $10.15 | $7.69 |
| P/E Ratio | ★ $18.95 | $141.65 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $6.56 | $32.49 |
| 52 Week High | $28.96 | $50.88 |
| Indicator | UMC | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 40.62 |
| Support Level | $16.54 | $33.52 |
| Resistance Level | $20.85 | $43.31 |
| Average True Range (ATR) | 0.62 | 1.66 |
| MACD | 0.03 | -0.30 |
| Stochastic Oscillator | 15.99 | 16.29 |
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with close to 5% market share in 2025 after TSMC and SMIC. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the US, and South Korea. UMC features a diverse customer base that includes Texas Instruments, MediaTek, Intel, Broadcom, Novatek, and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 19,000 people as of February 2025.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.